Valve Heart Disease Clinical Trial
Official title:
Identification of Non-gal, Non-HLA Antigens in Patients Implanted With Xenogenic Material
This study involves collecting serum samples from patients presenting for aortic valve replacement at Mayo Clinic, Rochester, MN. Serum samples will be collected pre-op, between 2 weeks and 3 months, between 3-11 months (optional), and between 12-18 months post-operatively. The patients antibodies in these serum samples will be used to capture proteins from the same type of tissue their replacement heart valves are made from (i.e., bovine/porcine pericardium - a non-human tissue which is currently used to make glutaraldehyde-fixed heart valves). The captured proteins will be identified, and compared over time (i.e., 0, 1, 3 and 12 months) to determine which proteins (i.e., antigens) in bovine/porcine pericardium that the patient is mounting an immune response towards.
Protein G HP SpinTrap columns will be used to capture IgG antibodies from patient serum pre-implant, between 2 weeks-3 months, between 3-11 months and between 12-18 months post-implant. These antibodies will be cross-linked to the column and then protein extracted from implant tissue (ie Native bovine/porcine pericardium) will be deglycosylated and run through the column. Antigenic proteins will be trapped and non-antigenic proteins will be washed through the column. These antigenic proteins will be eluted off the column and identified using LC-MS/MS. The proteins identified in the pre-implant elutant will be compared to the proteins in post-implant elutant to identify xenoantigens. Success criteria will be method validation by identification of previously known and new currently unknown xenoantigens. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06066970 -
Cardiac Biomarkers for the Quantification of Myocardial Damage After Cardiac Surgery
|
||
Recruiting |
NCT05079672 -
Efficacy and Safety of Dexmedetomidine in the Analgesic Prophylaxis , in Patients Undergoing Cardiovascular Surgery
|
Phase 4 | |
Completed |
NCT03347851 -
Post-surgical Aortic Hemodynamics After Aortic Valve Replacement
|
||
Active, not recruiting |
NCT03539458 -
Feasibility Study of the Tendyne Mitral Valve System in Mitral Annular Calcification
|
N/A | |
Completed |
NCT04328090 -
Evaluation of the Potential Impact of Computerized Antimicrobial Stewardship
|
N/A | |
Recruiting |
NCT04359030 -
Freestyle-Perimount Calcification Comparison
|
||
Completed |
NCT04958668 -
Prospective Evaluation of Volatile Sedation After Heart Valve Surgery
|
N/A | |
Completed |
NCT04598360 -
Release of Epoxyeicosatrienoic Acids From Erythrocytes During the Use of Extracorporeal Procedures (Heart-lung Machine)
|
N/A | |
Not yet recruiting |
NCT04118621 -
Role of Chest Ultrasound in Detection of Post-operative Pulmonary Complications After Cardiothoracic Surgery
|
||
Recruiting |
NCT06387446 -
Allogeneic Valve Transplantation
|
N/A | |
Recruiting |
NCT04843072 -
Balloon vs. Self Expanding Transcatheter Valve for Degenerated Bioprosthesis
|
N/A | |
Completed |
NCT05804500 -
RecoveryPlus Telerehab Platform Pilot Study
|
N/A | |
Recruiting |
NCT03885180 -
Randomized Evaluation of D-dimer Guiding dUration of Oral antiCoagulation thErapy
|
N/A | |
Completed |
NCT06154018 -
Heparin Reversal With Two Different Protamine Ratios After Cardiopulmonary By-pass.
|
N/A | |
Recruiting |
NCT06041308 -
Bioprothetic Valve Versus Mechanical Valve of Bioprothetic Valve Versus Mechanical Valve
|
||
Suspended |
NCT01571791 -
Perioperative Ketorolac-lidocaine in the Patients With Valvular Heart Diseases During Cesarean Delivery
|
Phase 2 | |
Completed |
NCT06261788 -
Efficacy and Safety of the Sync-AV II Temporary Cardiac Pacing Catheter
|
N/A | |
Completed |
NCT06079008 -
The Association of Cardiac Valve Calcification and 1-year Mortality After Lower-extremity Amputation in Diabetic Patients
|
||
Completed |
NCT04372654 -
Pilot Study Evaluating the Safety of Electroducer Sleeve Medical Device for Temporary Cardiac Stimulation During Percutaneous Cardiovascular Interventions, in All Kind of Patients
|
N/A | |
Active, not recruiting |
NCT03661398 -
Caisson Transcatheter Mitral Valve Replacement (TMVR)
|
N/A |